Home›Companies›Biotech & Pharma›Willow Neuroscience

Willow Neuroscience, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 10, 2023·Suggest an edit

About Willow Neuroscience

Willow Neuroscience is a private company based in Palo Alto, California. It has reported $2,099,700 raised in two offerings on Form D since January 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 6, 2016Jan 18, 2022amended Jul 10, 2023$2,074,500of $3.2M target19$109KEquity, OptionsRule 506(b)Form D/A ↗1 earlier filing
Mar 22, 2017Apr 5, 2017$25,200of $54,000 target3$8,400EquityRule 506(b)Form D ↗
Total, two offerings$2,099,700

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Willow Neuroscience's Form D filed Jul 10, 2023.

MS
Mark de Souza
Director and President
MJ

Earlier filings also listed Michael Venuti (executive officer, last listed Apr 2017) and John Kincaid (executive officer and director, last listed Apr 2017).

Sources

  1. SECWillow Neuroscience, Inc. Form D, filed Jan 18, 2022
  2. SECWillow Neuroscience, Inc. filing history